Overview
Emerging research highlights the impact of chronic aflatoxin exposure on vulnerable populations, including those who are immunocompromised, pregnant, or managing chronic conditions. Evidence links exposure to immune suppression, liver dysfunction, and increased disease progression.
Identifying mycotoxin exposure through tools like the MycoTOX Profile can support more informed clinical decision-making and targeted intervention.
You Might Also Like
View All News
Partner Podcast:
Tick-borne Infections and Neurodegenerative Disease
In this Functional Medicine Doc Talk podcast, Dr. Woeller interview Nicole Bell, CEO of Galaxy Diagnostics and author of “What Lurks in the Woods.” This memoir is about her husband’s harrowing regression into a neurodegenerative illness, and her experience in trying to find answers to help him.
Nicole Bell is an author, entrepreneur, and advocate for tick-borne and neurodegenerative diseases.
Partner Podcast: CEO Scott Mattivi Shares Mosaic Diagnostics’ Vision for the Future of Specialty Diagnostics
In this podcast interview, Dr. Woeller has a conversation with Scott Mattivi, CEO of Mosaic Diagnostics Laboratory (formally Great Plains Laboratory).
MosaicDX is Now Part of the Fullscript Labs Catalog
Mosaic Diagnostics Tests Now Available on Fullscript
We’re excited to announce a new partnership with Fullscript, a leading care delivery platform for integrative and functional medicine practitioners.
Mosaic Diagnostics Announces Appointment of Scott Mattivi as Chief Executive Officer
Mosaic Diagnostics, a leading provider of specialty diagnostics, is proud to announce the appointment of Scott Mattivi as its new Chief Executive Officer.
Stay Informed, Stay Ahead
Join the MosaicDX community and elevate your testing knowledge.